Imogene Dunn
Director/Board Member chez Data Quality Research Institute
Profil
Imogene Dunn is currently the Director at Data Quality Research Institute and the Senior Vice President-Biometrics & Regulatory at vTv Therapeutics LLC.
Previously, she worked as the VP-Statistics, Data Management & Informatics at Regeneron Pharmaceuticals, Inc. from 2003 to 2008.
She also held positions as Vice President-Data Sciences Strategic Services at PAREXEL International Corp., Vice President at Cato Research LLC, Vice President-Statistics & Data Management at Yamanouchi Pharma America, Inc., and Senior Vice President-Biometrics & Regulatory at vTv Therapeutics, Inc. Dr. Dunn received her undergraduate and graduate degrees from The University of North Carolina at Greensboro and her doctorate from The University of North Carolina at Charlotte.
Postes actifs de Imogene Dunn
| Sociétés | Poste | Début |
|---|---|---|
| Data Quality Research Institute | Director/Board Member | - |
vTv Therapeutics LLC
 vTv Therapeutics LLC Pharmaceuticals: MajorHealth Technology vTv Therapeutics LLC is a clinical-stage biopharmaceutical company which engages in the discovery and development of small molecule drug candidates to fill unmet medical needs. It focuses on treating metabolic diseases to minimize their long-term complications through end-organ protection. The company is headquartered in High Point, NC. | General Counsel | - |
Anciens postes connus de Imogene Dunn
| Sociétés | Poste | Fin |
|---|---|---|
| REGENERON PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/01/2008 |
| Yamanouchi Pharma America, Inc. | Corporate Officer/Principal | - |
Cato Research LLC
 Cato Research LLC Miscellaneous Commercial ServicesCommercial Services Cato Research LLC operates as an international regulatory and clinical contract research organization. It offers clinical strategy, clinical trial services, data management and biostatistics, medical and pharmacovigilance, medical writing, pharmacokinetics, preclinical/nonclinical services, project management, quality assurance, and regulatory affairs. The company was founded by Allen Cato and Lynda Sutton in 1988 and is headquartered in Durham, NC. | Corporate Officer/Principal | - |
| PAREXEL INTERNATIONAL CORPORATION | Corporate Officer/Principal | - |
| VTV THERAPEUTICS INC. | General Counsel | - |
Formation de Imogene Dunn
| The University of North Carolina at Greensboro | Graduate Degree |
| The University of North Carolina at Charlotte | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| REGENERON PHARMACEUTICALS, INC. | Health Technology |
| VTV THERAPEUTICS INC. | Health Technology |
| Entreprise privées | 5 |
|---|---|
PAREXEL International Corp.
 PAREXEL International Corp. Miscellaneous Commercial ServicesCommercial Services PAREXEL International Corp. provides biopharmaceutical services. It offers clinical research and logistics, medical communications, consulting, commercialization and advanced technology products and services for pharmaceutical, biotechnology and medical device industries. The company was founded in 1983 and is headquartered in Newton, MA. | Commercial Services |
Cato Research LLC
Cato Research LLC Miscellaneous Commercial ServicesCommercial Services Cato Research LLC operates as an international regulatory and clinical contract research organization. It offers clinical strategy, clinical trial services, data management and biostatistics, medical and pharmacovigilance, medical writing, pharmacokinetics, preclinical/nonclinical services, project management, quality assurance, and regulatory affairs. The company was founded by Allen Cato and Lynda Sutton in 1988 and is headquartered in Durham, NC. | Commercial Services |
| Yamanouchi Pharma America, Inc. | |
| Data Quality Research Institute | |
vTv Therapeutics LLC
vTv Therapeutics LLC Pharmaceuticals: MajorHealth Technology vTv Therapeutics LLC is a clinical-stage biopharmaceutical company which engages in the discovery and development of small molecule drug candidates to fill unmet medical needs. It focuses on treating metabolic diseases to minimize their long-term complications through end-organ protection. The company is headquartered in High Point, NC. | Health Technology |
